Amanat Acquisition Corp (NASDAQ:AMAN) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Nicholas Fernandez Other companies: JATT III Acquisition Corp (Director · Since at least Aug 25, 2026); JATT II Acquisition Corp (Chief Financial Officer · Since at least Apr 16, 2026); Liminatus Pharma, Inc. (Director · Apr 30, 2025 – Apr 30, 2025 · Past) | Chief Financial Officer · Since at least May 18, 2026 |
| Patrick Crutcher Other companies: Jasper Therapeutics, Inc. (Board Member · Since at least Jul 16, 2026); Avalo Therapeutics, Inc. (VP, Business Development · Sep 25, 2018 – Dec 20, 2018 · Past) | Director · Since at least May 18, 2026 |
| Pavan Cheruvu Other companies: Retension Pharmaceuticals, Inc. (Director · Since at least Nov 5, 2026); Sio Gene Therapies Inc (Chief Executive Officer, Director · Feb 11, 2018 – Dec 8, 2021 · Past) | Chief Executive Officer, Director · Since at least May 18, 2026 |
| Rakhi Kumar Other companies: NeuroPace, Inc. (Director · Since at least Jun 7, 2024); Roivant Sciences Ltd. (Chief Accounting Officer · Oct 24, 2023 – Feb 20, 2025 · Past) | Director · Since at least May 18, 2026 |
| Sandeep Kulkarni Other companies: Tourmaline Bio Inc. (CEO, Director · Since at least Oct 19, 2023); Zura Bio Limited (Co-Founder, Chief Executive Officer and Director · Since at least Mar 20, 2023) | Director and Chairman, Director · Since at least May 18, 2026 |
| W Bradford Middlekauff Other companies: Tourmaline Bio Inc. (CBO, GC and Secretary · Since at least Oct 28, 2025) | Director · Since at least May 18, 2026 |
| Ray Lyu | Corxel US Investor Relations · Since at least Oct 26, 2026 |